Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

Author： Helbig Grzegorz   Moskwa Andrzej   Hus Marek   Piszcz Jarosław   Swiderska Alina   Urbanowicz Alina   Całbecka Małgorzata   Seferyńska Ilona   Raźny Małgorzata   Rodzaj Marek   Żuk Ewa   Kyrcz-Krzemień Sławomira  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.67, Iss.4, 2011-04, pp. : 967-969

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Complete cytogenetic remission in a patient with FIP1L1-PDGFRA fusion negative chronic eosinophilic leukemia associated with atypical thrombotic events

By Zabernigg A.  

memo - Magazine of European Medical Oncology, Vol. 1, Iss. 1, 2008-03 ,pp. : 39-41

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

By Al-Riyami Arwa Z.  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1788-1790

Informa Healthcare

Access to resources Recommend Favorite

Alterations in the expression pattern of MTHFR, DHFR, TYMS, and SLC19A1 genes after treatment of laryngeal cancer cells with high and low doses of methotrexate

By Galbiatti Ana   Castro Rodrigo   Caldas Heloisa   Padovani João   Pavarino Érika   Goloni-Bertollo Eny  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3765-3771

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Syndecan-1 in Human B Cell Chronic Lymphocytic Leukaemia

By Sebestyen A.   Kovalszky I.   Mihalik R.   Gallai M.   Bocsi J.   Laszlo E.   Benedek S.   Sreter L.   Kopper L.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2273-2277

Elsevier

Access to resources Recommend Favorite

Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid

By Zhou Hong-Sheng   Dai Min   Wei Yongqiang   Wang Qiang   Xu Na   Yin Changxin   Meng Fanyi  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1557-1559

Informa Healthcare

Access to resources Recommend Favorite